首页> 外文期刊>Spine >Outcome of conservative surgery for giant cell tumor of the sacrum.
【24h】

Outcome of conservative surgery for giant cell tumor of the sacrum.

机译:骨巨细胞瘤保守治疗的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY DESIGN: Retrospective analysis. OBJECTIVE: To estimate the clinical outcome of conservative surgery (intralesional curettage or partial excision) aided by effective intraoperative hemorrhage control in patients with giant cell tumors of the sacrum. SUMMARY OF BACKGROUND DATA: Giant cell tumors of the sacrum present a challenging therapeutic problem. Wide resection is associated with higher morbidity and spinal instability. Whether conservative surgery aided by effective intraoperative hemorrhage control can achieve low recurrence rates remains uncertain. METHODS: The clinical records of 24 patients with an average age of 35 years who had undergone conservative surgery for sacral giant cell tumor between 1996 and 2005 were evaluated retrospectively. The disease onset, tumor size, operation records, complications, follow-up status, and functional outcome were analyzed. RESULTS: The mean duration of follow-up was 58 months (median, 50 months; range: 25-132 months). All the patients had a conservative procedure aided by intraoperative occlusion of the abdominal aorta. The mean estimated blood loss was 3217 mL. The mean length of the operation was 190 minutes. Seven (29.2%) patients developed recurrences. The mean time from the index surgical procedure to the first recurrence was 13 months (range: 8-31 months). The 5-year local recurrence-free survival rate was 69.6%. Seventeen (70.8%) patients retained normal urinary function and 16 (66.7%) patients preserved normal bowel function. No patients had urinary or bowel dysfunction when both S3 nerves were preserved. Ten (41.7%) patients had complications perioperatively or during the follow-up. Seven (29.2%) patients had wound complications. CONCLUSION: Considering the acceptable local recurrence rate, conservative surgery aided by effective control of intraoperative hemorrhage should be considered as an alternative procedure for patients with giant cell tumors of the sacrum. The advantages include lower morbidity, reduced neurologic deficits, speed and ease of the surgical procedure, reduced blood loss, preservation of spinal and pelvic continuity, and a low recurrence rate.
机译:研究设计:回顾性分析。目的:通过对effective骨巨细胞瘤患者进行有效的术中出血控制,评估保守手术(刮宫术或部分切除术)的临床效果。背景数据概述:the骨巨细胞瘤具有挑战性的治疗问题。广泛切除与较高的发病率和脊柱不稳相关。术中有效控制出血的保守手术能否达到较低的复发率仍不确定。方法:回顾性分析1996年至2005年间接受conservative骨巨细胞瘤保守手术的24例平均年龄为35岁的患者的临床资料。分析疾病的发作,肿瘤大小,手术记录,并发症,随访状况和功能结局。结果:平均随访时间为58个月(中位数为50个月;范围为25-132个月)。所有患者均在术中腹主动脉闭塞的辅助下进行了保守手术。平均估计失血量为3217 mL。手术的平均时间为190分钟。七名(29.2%)患者复发。从分期手术到第一次复发的平均时间为13个月(范围:8-31个月)。 5年局部无复发生存率为69.6%。十七名(70.8%)患者的尿功能正常,而十六名(66.7%)患者的肠功能正常。保留了S3两条神经后,没有患者出现尿或肠功能障碍。十名(41.7%)患者在术中或随访期间出现并发症。七名(29.2%)患者有伤口并发症。结论:考虑到可接受的局部复发率,对于effective骨巨细胞瘤患者,应考虑采取保守治疗并辅以有效控制术中出血的替代手术。优点包括较低的发病率,减少的神经系统缺陷,手术过程的速度和便利性,减少的失血量,保留脊柱和骨盆的连续性以及较低的复发率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号